Recombinant multi-species ARHGAP24 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARHGAP24 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a Rho-GTPase activating protein, which is specific for the small GTPase family member Rac. Binding of the encoded protein by filamin A targets it to sites of membrane protrusion, where it antognizes Rac. This results in suppression of lamellae formation and promotion of retraction to regulate cell polarity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
The Alternative Names of target: 0610025G21Rik,ARHGAP24,Arhgap24,DR-NR#2,FILGAP,Filamin-A-associated RhoGAP (FilGAP),RAC1- and CDC42-specific GTPase-activating protein of 72 kDa (RC-GAP72),RC-GAP72,RCGAP72,Rho GTPase-activating protein 24,Rho-type GTPase-activating protein 24,RhoGAP of 73 kDa,Sarcoma antigen NY-SAR-88,p73,p73RhoGAP

Target products collectionGo to ARHGAP24 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2349-Ag-1/ GM-Tg-hg-IP2349-Ag-2 Human ARHGAP24 protein Human
GM-Tg-rg-IP2349-Ag-1/ GM-Tg-rg-IP2349-Ag-2 Rat ARHGAP24 protein Rat
GM-Tg-mg-IP2349-Ag-1/ GM-Tg-mg-IP2349-Ag-2 Mouse ARHGAP24 protein Mouse
GM-Tg-cynog-IP2349-Ag-1/ GM-Tg-cynog-IP2349-Ag-2 Cynomolgus/Rhesus macaque ARHGAP24 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2349-Ag-1/ GM-Tg-felg-IP2349-Ag-2 Feline ARHGAP24 protein Feline
GM-Tg-cang-IP2349-Ag-1/ GM-Tg-cang-IP2349-Ag-2 Canine ARHGAP24 protein Canine
GM-Tg-bovg-IP2349-Ag-1/ GM-Tg-bovg-IP2349-Ag-2 Bovine ARHGAP24 protein Bovine
GM-Tg-equg-IP2349-Ag-1/ GM-Tg-equg-IP2349-Ag-2 Equine ARHGAP24 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2349-Ag-1/ GM-Tg-hg-IP2349-Ag-2; GM-Tg-rg-IP2349-Ag-1/ GM-Tg-rg-IP2349-Ag-2;
GM-Tg-mg-IP2349-Ag-1/ GM-Tg-mg-IP2349-Ag-2; GM-Tg-cynog-IP2349-Ag-1/ GM-Tg-cynog-IP2349-Ag-2;
GM-Tg-felg-IP2349-Ag-1/ GM-Tg-felg-IP2349-Ag-2; GM-Tg-cang-IP2349-Ag-1/ GM-Tg-cang-IP2349-Ag-2;
GM-Tg-bovg-IP2349-Ag-1/ GM-Tg-bovg-IP2349-Ag-2; GM-Tg-equg-IP2349-Ag-1/ GM-Tg-equg-IP2349-Ag-2
Products Name ARHGAP24 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ARHGAP24
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARHGAP24 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.